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PR
OWe investigated the involvement of mitochondrial-dependent apoptosis in Huntington's disease (HD) vs.
control (CTR) cybrids, obtained from the fusion of human platelets with mitochondrial DNA-depleted NT2
cells, and further exposed to 3-nitropropionic acid (3-NP) or staurosporine (STS). Untreated HD cybrids did
not exhibit signiﬁcant modiﬁcations in the activity of mitochondrial respiratory chain complexes I–IV or in
mtDNA sequence variations suggestive of a primary role in mitochondrial susceptibility in the subpopulation
of HD carriers studied. However, a slight decrease in mitochondrial membrane potential and increased
formation of intracellular hydroperoxides was observed in HD cybrids under basal conditions. Furthermore,
apoptotic nuclei morphology and a moderate increase in caspase-3 activation, as well as increased levels of
superoxide ions and hydroperoxides were observed in HD cybrids upon 3-NP or STS treatment. 3-NP-evoked
apoptosis in HD cybrids involved cytochrome c and AIF release from mitochondria, which was associated
with mitochondrial Bax translocation. CTR cybrids subjected to 3-NP showed increased mitochondrial Bax
and Bim levels and the release of AIF, but not cytochrome c, suggesting a different mode of cell death, linked
to the loss of membrane integrity. Additionally, increased mitochondrial Bim and Bak levels, and a slight
release of cytochrome c in untreated HD cybrids may help to explain their moderate susceptibility to
mitochondrial-dependent apoptosis.39
Cell Biology, and Institute of
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Huntington's disease (HD) is an autosomal dominant disorder
characterized by uncontrolled body movements known as chorea,
changes in personality and a loss of cognitive ability eventually
leading to dementia. HD is caused by an expansion of the trinucleotide
CAG repeat in the huntingtin gene, producing a proteinwith increased
number of polyglutamines at the N-terminal (mutant huntingtin).
Neuropathological changes are caused by the death of GABAergic
projection medium-spiny neurons of the neostriatum (caudate and
putamen) and neurons in the cerebral cortex, the two most severely
affected brain structures in HD (e.g., Gil and Rego, 2008). However,
the mechanisms by which mutant huntingtin causes selective
degeneration of striatal and cortical neurons in HD are largely
unknown.
Neuronal abnormalities involving aberrant protein–protein inter-
actions caused bymutant huntingtinmay lead to deregulation in gene77
78
79
80
81expression in human HD striatum (Kuhn et al., 2007). Furthermore,
excitotoxicity linked to decreased Ca2+ homeostasis, mitochondrial
dysfunction, impairment in energy metabolism (Schapira, 1998; Beal,
2005; Sas et al., 2007; Sorolla et al., 2008; Yang et al., 2008), caspase
activation and apoptosis (Brouillet et al., 1998; Beal, 2005; Milakovic
and Johnson, 2005; Rego and de Almeida, 2005; Fan and Raymond,
2007) have been reported in HD-affected individuals. In addition,
oxidative stress and damage to speciﬁc macromolecules also
participate in HD progression (Sorolla et al., 2008).
Analysis of post-mortem striatal tissue from HD patients revealed
a decrease in the activity of the respiratory chain complexes II/III and
IV (Schapira 1998; Tabrizi et al., 1999). Mutant huntingtin may cause
mitochondrial dysfunction by either perturbing transcription of
nuclear-encoded mitochondrial proteins or by directly interacting
with the organelle, thus evoking defects in mitochondrial dynamics,
organelle trafﬁcking and ﬁssion and fusion, which, in turn, may result
in bioenergetic failure in HD (Bossy-Wetzel et al., 2008). Indeed, mild
or gradual energy disturbances may lead to the release of pro-
apoptotic factors from the mitochondria, such as cytochrome c,
leading to apoptotic cell death. However, if the energy supply of the
cell drops dramatically, cells die by necrosis (Vanlangenakker et al.,
2008).gton's disease human cybrids, Exp. Neurol. (2010),
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Mutant huntingtin is widely expressed in the HD brain (Aronin
et al., 1995; Trottier et al., 1995), but also in peripheral tissues.
Thus, abnormalities outside the brain can also be expected. Accordingly,
mutant huntingtin was reported to be associated with mitochondrial
complex II/III dysfunction, mitochondrial depolarization, cytochrome c
release and increased caspases activity in skeletal muscle (Ciammola et
al., 2006; Turner et al., 2007), and decreased catalase activity in skin
ﬁbroblast cultures from HD patients (del Hoyo et al., 2006). Lympho-
blasts derived from HD patients also show increased stress-induced
apoptotic cell death associated with caspase-3 activation, abnormal
calcium homeostasis and mitochondrial dysfunction (Sawa et al., 1999;
Panov et al., 2002; Bezprozvanny and Hayden, 2004). Recently, we
demonstrated that HD human peripheral blood cells, particularly B
lymphocytes, are endowed with increased expression of Bax and
decreased mitochondrial membrane potential (Almeida et al., 2008),
further suggesting that an adverse effect of mutant huntingtin is not
limited to neurons.
It is widely accepted that mitochondrial DNA (mtDNA) abnormal-
ities play an important role in neurodegenerative diseases (Grazina et
al., 2006; Onyango et al., 2006), even if they are not a primary
triggering factor (Mancuso et al., 2008). mtDNA mutations may
modify the age of onset, as a result of an impairment of mitochondrial
respiratory chain and/or translational mechanisms thus contributing
to the neurodegenerative process (Grazina et al., 2006). Even though
the studies concerning HD and mtDNA mutations are rare and
heterogeneous, mtDNAmutations have been suggested to occur in HD
pathophysiology (Kasraie et al., 2008; Yang et al., 2008). It was
recently demonstrated that mitochondrial DNA damage is an early
biomarker for HD-associated neurodegeneration supporting the
hypothesis that mtDNA lesions may contribute to the pathogenesis
observed in HD (Acevedo-Torres et al., 2009). Indeed, recent data
showed that HD patients' lymphocytes have higher frequencies of
mtDNA deletions and oxidative stress, suggesting that CAG repeats
instability and mutant huntingtin are a causative factor in mtDNA
damage (Banoei et al., 2007). Nevertheless, previous studies in HD
cybrids (a valuable cellular tool to isolate mitochondrial-encoded
human defects) showed no changes in mitochondrial respiratory
chain activity or oxidative stress (Swerdlow et al., 1999), evidencing
no major changes in mitochondrial function, even if considering the
occurrence of point mtDNA mutations. Notwithstanding, mutant
huntingtin was previously shown to interact with neuronal mito-
chondria of YAC72 transgenic mice suggesting that mitochondrial
calcium abnormalities associatedwith HD pathogenesismay be due to
a direct effect of mutant huntingtin on the organelle (Panov et al.,
2002). Moreover, mutant huntingtin fragments can directly induce
the opening of the mitochondrial permeability transition pore in
isolated mouse liver mitochondria, with the consequent release of
cytochrome c (Choo et al., 2004), favoring the hypothesis that mutant
huntingtin interacting with mitochondria may well lead to mito-
chondrial modiﬁcations independently of damage on mtDNA.
Thus, in the present study, we studied mitochondrial-dependent
apoptotic events and oxidative stress in human cybrid lines, obtained
from the fusion of HD or control platelets with NT2 ρ0 cells, depleted
of mitochondrial DNA. We report increased susceptibility of a
subpopulation of HD cybrids, an ex vivo mitochondrial HD human
model, to undergo mitochondrial-dependent apoptosis when sub-
jected to complex II inhibition with 3-nitropropionic acid (3-NP) or to
apoptosis with the classic inducer staurosporine (STS).
Materials and methods
Materials
Optimem was purchased from GIBCO (Paisley, UK). Protease
inhibitor cocktail (chymostatin, pepstatin, A, leupeptin and antipain),
3-nitropropionic acid, penicillin/streptomycin, oligomycin, carbonyl-Please cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
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cyanide-p-(triﬂuoromethoxyphenyl)hydrazone (FCCP), dichlorphe-
nolindophenol (DCPIP), thenoyltriﬂuoroacetone (TTFA), 5,59-
dithiobis (2-nitrobenzoic acid) (DTNB) and anti-α-tubulin were
from Sigma Chemical Co. (St Louis, MO, USA). N-acetyl-Asp-Glu-Val-
Asp-p-nitroanilide (Ac-DEVD-pNA) was obtained from Calbiochem
(Darmstadt, Germany). Anti-cytochrome c was from BD Pharmingen
(San Diego, CA, USA); anti-Bax from Cell Signaling (Beverly, MA,
USA); anti-Bcl-2 and anti-AIF from Santa Cruz Biotechnology (Santa
Cruz, CA, USA); anti-Bim from Stressgen (Assay Designs, Inc.,
Michigan, USA); and anti-Bak from Abcam Inc. (Cambridge, USA).
Secondary antibodies conjugated to alkaline phosphatase (anti-
mouse and anti-rabbit) were purchased from Amersham Biosciences
(Buckinghamshire, UK). The ﬂuorescence probes tetramethylrhoda-
mine methyl ester (TMRM+), dihydroethidium (DHE), 2′,7′-dichlor-
odihydroﬂuorescein diacetate (DCFH2-DA), Hoechst 33342 and anti-
cytochrome c oxidase I (COX I) were obtained from Molecular Probes
(Invitrogen, USA). All other reagents were of analytical grade.
Participants
Five to six genetically and clinically conﬁrmed HD patients from
pre-identiﬁed Portuguese families and three age-matched healthy
controls, without any neurological disease, were studied. The number
of CAG repeats present in HD gene for all the patients were between
42 and 44, which gives rise to the most common adult-onset form of
the disease. The patients were characterized according to the Uniﬁed
Huntington's Disease Rating Scale (UHDRS) (Huntington Study
Group, 1996) and neurological evaluation was performed by an
experienced neurologist. The studywas performed in accordancewith
the Ethical Committee of Coimbra University Hospital, and all the
subjects gave informed consent.
Cybrid production, culture and incubation with 3-NP and STS
Cybrids (cytoplasmic hybrid systems) were produced after fusion
of mitochondrial DNA-depleted human teratocarcinoma cells (ρ° NT2
cells), obtained from Dr. R. H. Swerdlow (University of Virginia,
Charlottesville, VA, USA), with human platelets. Production and
selection of the cybrids were performed as described previously
(Cardoso et al., 2004). Cybrids were cultured in Optimem medium
supplemented with 10% of fetal calf serum, penicillin (100 U/ml),
streptomycin (100 μg/ml) and maintained at 37 °C in humidiﬁed
incubator containing 95% air and 5% CO2. Since mitochondria divide
mainly in response to the energy needs of the cell, i.e., independently
of the cell cycle (Sas et al., 2007) and to account for the auto-selection
of the remaining functional mitochondria, experiments were per-
formed with cybrids less than 2 months in culture, as previously
described (e.g., Cardoso et al., 2004). Cybrids were plated on glass
coverslips, multiwell chambers or ﬂasks at a density of 0.06×106
cells/cm2 one day before the experiments in order to allow the
desired conﬂuence. Cells were then incubated in culture medium in
the absence or presence of 3-NP (0.1, 1 or 10 mM) for 24 h or STS (0.1,
1 or 10 nM) for 15 h, as described in ﬁgure legends.
Assay of enzymatic activities of mitochondrial electron transport chain
Cybrids were extracted in a sucrose buffer (250 mM sucrose;
20 mM HEPES-KOH, pH 7.5; 100 mM KCl; 1.5 mMMgCl2; 1 mM EDTA
and 1 mM EGTA), and centrifuged at 2300 rpm for 12 min at 4 °C. The
supernatant was analyzed for mitochondrial complex activities on a
UV/VIS spectrophotometer (model 2401; Shimadzu Scientiﬁc Instru-
ments, Columbia, MD).
NADH–ubiquinone oxidoreductase assay
Complex I activity was determined at 340 nm by following the
decrease in NADH absorbance that occurs when ubiquinone isoptosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
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reduced to ubiquinol. The reaction was started by adding the sample
to the reaction mixture (in mM: 20 K2HPO4, pH 7.2, 10 MgCl2, 0.15
NADH, 2.5 mg/ml BSA fatty-acid free, 1 KCN) containing 50 μM
decylubiquinone, at 30 °C. After 8 min, rotenone (10 μM) was added
and the reaction was registered for further 8 min. Complex I activity
was expressed in nanomoles per minute per milligram of protein and
correspond to the rotenone sensitive rate. The enzyme activity was
corrected for citrate synthase activity.
Succinate–ubiquinone oxidoreductase assay
Complex II activity was monitored at 600 nm by following the
reduction of 6,6-dichlorophenolindophenol (DCPIP) by the ubiquinol
formed in the reaction. The assay was started by adding the sample to
the reaction mixture (in mM: 50 K2HPO4, pH 7.4, 20 succinate, 0.1
EDTA, 1 KCN, 0.01 rotenone) containing 50 μM decylubiquinone, at
30 °C. After 8 min, 1 mM 2-thenoyltriﬂuoroacetone (TTFA) was added
and the reaction registered for further 8 min. Complex II activity was
expressed in nanomoles per minute per milligram of protein and
correspond to the TTFA sensitive rate. The enzyme activity was
corrected for citrate synthase activity.
Ubiquinol–cytochrome c reductase assay
Complex III activity was monitored at 550 nm by following the
reduction of cytochrome c by ubiquinol. The assay was started by
adding the sample to the reactionmixture (inmM: 35 K2HPO4, pH 7.2,
1 EDTA, 5MgCl2, 1 KCN, 5 μM rotenone) containing 15 μM cytochrome
c and 15 μM ubiquinol, at 30 °C. Complex III activity was expressed in
rate constant (k) per minute per milligram of protein and corrected
for citrate synthase activity.
Cytochrome c oxidase assay
Complex IV activity was determined at 550 nm by measuring the
oxidation of reduced cytochrome c by cytochrome c oxidase. The
reduced cytochrome c was prepared by mixing its oxidized form with
ascorbate and then dialysed for 24 h against a 0.01 M phosphate
buffer, pH 7.0, at 4 °C. The assay was started by adding the sample to
the reaction buffer (10 mM K2HPO4, pH 7) containing 50 μM reduced
cytochrome c and 1mM ferricyanide, at 30 °C. Complex IV activity was
expressed in rate constant (k) perminute permilligram of protein and
corrected for citrate synthase activity.
Citrate synthase assay
Citrate synthase (CS) activity was performed at 412 nm following
the reduction of 0.2 mM 5,5′-dithio-bis(2-nitrobenzoic acid) in the
presence of 0.2 mM acetyl-CoA and 0.1 mM oxaloacetate in a medium
with 100 mM Tris–HCl, pH 8.0 and 0.1% Triton X-100. CS activity was
expressed in nanomoles per minute per milligram of protein.
Analysis of mitochondrial membrane potential
The mitochondria membrane potential was determined by using
the cationic ﬂuorescent probe tetramethyl rhodamine methyl ester
(TMRM+), which accumulates predominantly in polarized mitochon-
dria (Ward et al., 2000). Thus the variation of TMRM+ retention was
studied in order to estimate changes in mitochondrial membrane
potential. Following a washing step with Na+ medium containing (in
mM): 135 NaCl, 5 KCl, 0.4 KH2PO4, 1.8 CaCl2, 1 MgSO4, 20 HEPES, and
5.5 glucose, pH 7.4, cells were incubated in Na+ medium containing
150 nM TMRM+ (quench mode) for 1 h at 37 °C. Basal ﬂuorescence
(540 nm excitation and 590 emission) was measured using a
Microplate Spectroﬂuorometer Gemini EM (Molecular Devices, USA)
for 5 min, followed by the addition of 1 μM FCCP and 2 μg/ml
oligomycin, which produced maximal mitochondrial depolarization.
Results were expressed as the difference between the increase of
TMRM+ ﬂuorescence upon addition of FCCP plus oligomycin and basal
ﬂuorescence values.Please cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
doi:10.1016/j.expneurol.2010.01.002TE
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Analysis of apoptotic nuclei
The nuclear morphology of HD and CTR cybrids exposed to 3-NP
or STS was analyzed by ﬂuorescence microscopy, by using a double-
staining procedure with Hoechst 33342 and propidium iodide.
Following a washing step with Na+ medium, the cells were
incubated with 7.5 μg/ml Hoechst 33342 and 4 μg/ml propidium
iodide, in the dark, for 3 min, at room temperature. Cells were
washed 3 times in Na+ medium in order to remove extracellular
dyes and further examined and scored using the Axioscope 2 Plus
upright microscope (Zeiss, Jena, Germany).
Lactate dehydrogenase (LDH) measurements
The integrity of the plasma membrane was determined by
monitoring the activity of the cytoplasmic enzyme LDH in the
extracellular incubation medium, which represents a common proce-
dure to determine membrane leakage and necrotic cell damage. After
exposure to 3-NP or STS, the incubation medium was collected
(extracellular) and the cells were lysed in 10 mM HEPES (pH 7.4) plus
0.01% Triton X-100 (intracellular) and frozen at −80 °C. Cell debris in
both sampleswere removedby centrifugation at 14,000 rpm(Eppendorf
Centrifuge 5417R), for 10 min. LDH was determined spectrophotomet-
rically, by following the rate of conversion of reduced nicotinamide
adenine dinucleotide (NADH) to oxidized NAD+ at 340 nm (Bergmeyer
and Bernt, 1974). LDH released into the extracellular medium was
expressed as a percentage of the total LDH activity in the cells [% of LDH
released=extracellular LDH/(extracellular LDH+ intracellular LDH)].
Analysis of intracellular superoxide ions
The cybridswere incubated for 60minat 37 °C in thepresenceof 5 μM
DHE, in Na+medium. DHE is a cell-permeable ﬂuorescent dye that, once
internalized, is oxidized by superoxide to ﬂuorescent ethidium bromide,
which intercalates into DNA. DHE itself shows a blue ﬂuorescence
(355nmexcitation, 420nmemission) in cell cytoplasmuntil oxidation to
form ethidium, which becomes red ﬂuorescent (518 nm excitation,
605 nm emission) upon DNA intercalation. Ethidium bromide ﬂuores-
cence intensity was measured continuously for 1 h at 37 °C, and the
relative level of superoxide production quantiﬁed, using a Microplate
Spectroﬂuorometer Gemini EM (Molecular Devices, USA). At the end of
each experiment, the cells were scrapped to quantify cell protein in each
well, using the BioRad protein assay, and ethidium ﬂuorescence was
corrected for variations in total protein between wells. The values were
normalized to the percentage of control (untreated cybrids).
Intracellular hydroperoxides analysis
Cybrids were incubated for 30 min in the presence of 20 μM
DCFH2-DA, a stable non-ﬂuorescent cell permeable compound, at
37 °C in Na+ medium, pH 7.4. When internalized by the cell, DCFH2-
DA is hydrolyzed to DCFH2 by intracellular esterases and rapidly
oxidized to the highly green ﬂuorescent component 2,7-dichloro-
ﬂuorescein (DCF) by endogenous hydroperoxides. Intracellular levels
of peroxides were measured by following DCF ﬂuorescence (480 nm
excitation, 550 nm emission) at 37 °C continuously for 1 h, using a
microplate reader Spectroﬂuorometer Gemini EM (Molecular Devices,
USA). In order to correct the DCF ﬂuorescence values for variations in
total protein content in the wells, cell protein in each well was
quantiﬁed by the BioRad protein assay. The values were normalized to
the percentage of the control (untreated cybrids).
Caspase-3 activity assay
After washing, cells were scrapped at 4 °C in lysis buffer containing
25 mM HEPES, 2 mM MgCl2, 1 mM EDTA and 1 mM EGTA, pH 7.5,optosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
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ﬂuoride (PMSF) and 1:1000 of protease inhibitor cocktail (chymos-
tatin, pepstatin A, leupeptin and antipain). Cells were frozen two
times in liquid N2 and centrifuged at 14,000 rpm for 10 min
(Eppendorf Centrifuge 5417R). The resulting supernatants were
assayed for protein content by the BioRad protein assay. To measure
caspase-3 activity, 30 μg protein were added to a reaction buffer
[25 mM HEPES, 10% (m/v) sucrose, 0.1% (m/v) 3-[(3-cholamidopro-
pyl) dimethylammonio]-1-propane-sulfonate CHAPS), pH 7.5] con-
taining the colorimetric substrate (100 μM) for caspase-3 (Ac-DEVD-
pNA)-like activity. The reactionmixturewas incubated at 37 °C for 2 h,
and the formation of pNAwas measured at 405 nm using amicroplate
reader Spectra Max Plus 384 (Molecular Devices, USA). Caspase-like
activity was calculated as the increase above control for equal amount
of loaded protein.UN
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Fig. 1. Mitochondrial speciﬁc activities of complexes I-IV and mitochondrial membrane
normalized for the activity of citrate synthase (E) and mitochondrial membrane potential (
were observed in the respiratory complexes activities. Data are the mean±S.E.M. of 6–8 in
two-way ANOVA, followed by Bonferroni post test. ⁎pb0.05, ⁎⁎pb0.01 when compared to
Please cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
doi:10.1016/j.expneurol.2010.01.002Western blot analysis in mitochondrial and cytosolic subcellular fractions
After a washing step, cybrids were scrapped at 4 °C in sucrose
buffer containing 250 mM sucrose, 20 mM HEPES, 100 mM KCl,
1.5 mM MgCl2, 1 mM EDTA and 1 mM EGTA, pH7.5/KOH,
supplemented with 1 mM DTT, 1 mM PMSF and 1:1000 protease
cocktail inhibitor (chymostatin, pepstatin A, leupeptin and antipain).
Cellular extracts were homogenized (20 strokes) and centrifuged at
500×g for 12 min to pellet the nucleus and cell debris. The
supernatant was further centrifuged at 12,000×g for 20 min and
the resulting pellet (mitochondrial fraction) was resuspended in
supplemented TNC buffer containing 10 mM Tris acetate pH 8, 0.5%
Nonidet P40, 5 mM CaCl2 supplemented with 1:1000 of protease
cocktail inhibitor. TCA 15% was added to the supernatant and
centrifuged at 15,000×g for 10 min. The resulting pellet (cytosolicTE
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potential in HD and CTR cybrids. Mitochondrial complex enzymatic activities (A–D)
F) were determined as described in Materials and methods. No signiﬁcant differences
dependent experiments performed in duplicates. Statistical analysis was performed by
CTR cybrids; ###pb0.001 when compared to control (untreated) conditions.
optosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
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Table 1 t1:1
Summary of mtDNA investigation in HD and control cybrids.
t1:2
t1:3Sample mtDNA
sequence
variations
Status (according to MITOMAP) Gene
t1:4HD-1 None
t1:5HD-2 None
t1:6HD-3 3348ANG CRP MTND1
t1:711719GNA CRP UnP in oral cancer MTND4
t1:814766CNT CRP MTCYB
t1:9HD-4 3618TNC⁎ CRP MTND1
t1:10HD-5 3394TNC CRP; SM in acute leukaemia; PM “unclear”
in LHON/NIDDM/CPT deﬁciency
MTND1
t1:114216TNC CRP; haplogrup marker JT MTND1
t1:1211719GNA CRP; UnP in oral cancer MTND4
t1:1313708GNA CRP; haplogroup marker J MTND5
t1:1414766CNT CRP MTCYB
t1:1514798TNC CRP MTCYB
t1:16CTR-1 7621TNC CRP MTCO2
t1:178291ANG Novel MTNC7
t1:18CTR-2 3348ANG CRP MTND1
t1:194172TNA Novel MTND1
t1:207566GNA⁎ Novel MTTD
(tRNA
asp)
t1:2111719GNA CRP; UnP in oral cancer MTND4
t1:2211938CNT CRP MTND4
t1:2314766CNT CRP MTCYB
t1:24CTR-3 3348ANG CRP MTND1
t1:254172TNA Novel MTND1
t1:267566GNA⁎ Novel MTTD
(tRNA
asp)
t1:2711719GNA CRP; UnP in oral cancer MTND4
t1:2811938CNT CRP MTND4
t1:2914766CNT CRP MTCYB
Note: the nomenclature of genes is presented according to MITOMAP; CRP: coding
region polymorphism; ⁎heteroplasmy; SM: somatic mutation; PM: point mutation;
UnP: unpublished polymorphism; LHON: Leber hereditary optic neuropathy; NIDDM:
non-insulin dependent diabetes mellitus; CPT: carnitine palmitoyl transferase. t1:30
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fraction) was resuspended in supplemented sucrose buffer and
adjusted to pH 7 with 2.5 M KOH. Protein content was determined
by BioRad method, and the samples were denaturated with 6 times
concentrated denaturating buffer at 95 °C, for 5 min. Equivalent
amounts of protein were separated on a 15% SDS-PAGE gel
electrophoresis and electroblotted onto polyvinylidene diﬂuoride
(PVDF) membranes. The membranes were further blocked with 5%
fat-free milk and incubated with antibodies directed against the
denatured form of cytochrome c (Cyt c, 1:500), AIF (1.1000), Bax
(1:1000), Bim (1:1000), Bak (1:5000), Bcl-2 (1:500), α-tubulin
(1:20000) and mitochondrial DNA-encoded cytochrome c oxidase
subunit I (COX-I, 1:500). In somemembranes retainingmitochondrial
samples where labeling with COX-I was not possible, we used the
antibody directed against α-tubulin (1:20000) to normalize the
amount of protein per lane. Tubulin is an inherent component of
mitochondrial membranes (Carré et al., 2002) and its levels did not
change in any of the treatments used in this study. Immunoreactive
bands were visualized by alkaline phosphatase activity after incuba-
tion with ECF reagent on a BioRad Versa Doc 3000 Imaging System.
Mitochondrial DNA (mtDNA) screening
Total DNA was extracted from 5 HD and 3 CTR cybrids by using
standard methods (Treco et al., 1992) and quantiﬁed by UV
spectrophotometry (λ=260 nm). Automated sequencing analysis
were used, according to the manufacturer's instructions (3130 ABI
Prism sequencing system), using BigDye® Terminator Ready Reaction
Mix v1.1 (Applied Biosystems), for investigation of 11 mtDNA regions
corresponding to nucleotides 1435-1917, 3150-3769, 4074-4703,
4886-5021, 7241-7644, 8222-8461, 8915-9413, 11720-11819, 13515-
13727, 14420-14855, 15023-15450, allowing the screening of 31
conﬁrmed pathogenic mutations, 105 reported mutations and 288
polymorphisms, including 4 haplogroup markers, according to
MITOMAP (www.mitomap.org). Evolutionary conservation analysis
among species for positions with novel variants identiﬁed was
achieved using ENSEMBL® tools.
Statistical analysis
No signiﬁcant differences in biochemical studies were observed
between the HD cybrid lines and the three CTR cybrids used in this
work. Therefore data were expressed as the mean±S.E.M. of the
number of experiments indicated in the ﬁgure legends. Comparisons
between multiple groups were performed with a two-way analysis of
variance (ANOVA), followed by Bonferroni post-test for comparison
between experimental groups. Student's t test was also performed for
comparison between two Gaussian populations, as described in ﬁgure
legends. Signiﬁcance was accepted at pb0.05.
Results
Mitochondrial electron transport chain activities and mitochondrial
membrane potential
We measured the activity of mitochondrial respiratory chain
complexes and the mitochondrial membrane potential in HD and CTR
cybrids. Our data show no signiﬁcant changes in the activities of
respiratory complexes I, II, III and IV (Figs. 1A–D) or citrate synthase
(Fig. 1E) in HD vs. CTR cybrids. Although the putative basal leak
current and the coupling between oxygen consumption and ATP
synthesis may be underestimated by assaying the catalytic activities
of mitochondrial complexes, the latter measurement is important to
evaluate putative changes between our HD cybrids and the data
generated by Swerdlow et al. (1999).
We determined TMRM+ mitochondrial accumulation after com-
plete mitochondrial depolarization due to the addition of FCCP plusPlease cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
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oligomycin, which gave rise to a measurable “spike” of cell
ﬂuorescence as a result of TMRM+ dequenching. We observed a
slight, but signiﬁcant, decrease in TMRM+ release frommitochondria,
suggestive of decreased mitochondrial membrane potential in
untreated HD cybrids (Fig. 1F). The 3-NP evoked decrease in TMRM+
release was similarly exacerbated (50% decrease, pb0.001) upon
exposure of both HD and CTR cybrids to 10mM 3-NP, but not 1 mM 3-
NP (Fig. 1F).
Mitochondrial DNA (mtDNA) screening
Despite the lack of differences in mitochondrial complexes
activities, both HD and CTR cybrids were subjected for mtDNA
screening. Results depicted in Table 1 summarize mtDNA ﬁndings in
cybrids derived from HD patients and CTR subjects. The results were
heterogeneous, revealing different patterns of mtDNA variations, both
in controls and HD patients and sequence variations were found in 3
(60%) out of 5 patients. One pathogenic mutation, 3394A N G, with
status “unclear,” according to MITOMAP (www.mitomap.org) was
found in one (HD-5) of 5 patients (20%) with 38-year-olds and 25/44
CAG repeats genotype, together with other polymorphic variants.
Furthermore, we found 3 novel sequence variations in the control
subjects, occurring in genetic regions that are phylogenetically
moderate or highly conserved.
Effect of 3-NP and STS on cell viability
In order to evaluate the susceptibility of HD vs. CTR cybrids, we
studied the effect of 3-NP and STS on nuclei morphology and LDH
release. The cybrids were incubated with 1 and 10 mM 3-NP (Figs. 2A,optosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
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Fig. 2. Apoptotic and necrotic cell death induced by 3-NP (A, B, and E) or STS (C, D, and E) in HD andCTR cybrids. Cells cultured in glass coverslipswere incubatedwith 3-NP (1, 10mM)
or STS (1, 10 nM) for 24 h or 15 h, respectively. At the end of the incubation the cells were incubated for 3 min with Hoechst 33342 plus propidium iodide and observed under
ﬂuorescencemicroscopy for nuclei morphology (200–300 cells per ﬁeld and 3 ﬁelds per conditionwere counted). (E) shows a representative image of the cells. Data are themean±S.
E.M. of 3 independent experiments performed in duplicates. Statistical analysis was performed by two-way ANOVA, followed by Bonferroni post test. ⁎pb0.05, ⁎⁎pb0.01 when
compared to CTR cybrids; #pb0.05, ##pb0.01 and ###pb0.001 when compared to control (untreated) conditions.
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ARTICLE IN PRESSB and E) or 1 and 10 nM STS (Figs. 2C–E) and compared with non-
treated cells (control). A signiﬁcant number of apoptotic cells
displaying condensed and/or fragmented chromatin was observed
in HD cybrids incubated with 1 mM 3-NP (pb0.05) and 10 mM 3-NP
(pb0.001) when compared to untreated HD cybrids (Fig. 2A). In these
conditions, CTR cybrids exhibited a signiﬁcant increase in the number
of apoptotic cells only when incubated in the presence of 10 mM 3-NP
(pb0.01) (Fig. 2A). For the higher 3-NP concentration tested a
signiﬁcant difference between HD and CTR cybrids was observed
(pb0.01), suggesting an increased susceptibility of HD cybrids to
undergo an apoptotic mode of cell death upon exposure to 3-NP (Fig.
2A). Incubation of HD and CTR cybrids with 1 mM 3-NP did not
signiﬁcantly affect the number of necrotic cells, compared to
untreated conditions (control) (Fig. 2B). Conversely, CTR cybrids
exhibited morphological characteristics of necrosis following expo-
sure to 10 mM 3-NP, which were signiﬁcantly more evident than in
HD cybrids (pb0.01) (Fig. 2B). These results evidence a higher
susceptibility of CTR cybrids to undergo a necrotic mode of cell death
mode in response to 3-NP exposure. Analysis of LDH release
conﬁrmed these observations (Fig. 3A). A signiﬁcant increase in LDH
release was observed in both CTR and HD cybrids subjected to 10 mM
3-NP; however, CTR cybrids showed a preferential mode of necrotic
cell death, as determined by a higher loss of plasma membrane
integrity (Fig. 3A).
We also tested the effect of STS on apoptotic and necrotic nuclei
morphology on both HD and CTR cybrids (Figs. 2C–E). Our resultsUN
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Fig. 3. Effect of 3-NP (A) or STS (B) on LDH release in HD and CTR cybrids. Cells were
incubated in the absence or in the presence of 3-NP (1, 10 mM) or STS (1, 10 nM) for 24
h or 15 h, respectively, and LDHwas determined spectrophotometrically as described in
the Material and Methods. Data are the mean±S.E.M. of 4–8 independent experiments
performed in duplicates. Statistical analysis was performed by two-way ANOVA,
followed by Bonferroni post test. ⁎⁎⁎pb0.001 when compared to HD cybrids and
###pb0.001 when compared to control (untreated) conditions.
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show that 1 nM STS produced a small, but signiﬁcant, increase in the
number of HD cybrids undergoing apoptosis, compared with CTR
cybrids (pb0.05) (Fig. 2C). This effect was more pronounced in the
presence of 10 nM STS, since both CTR (pb0.01) and HD cybrids
(pb0.001) showed a higher number of apoptotic nuclei compared to
untreated cybrids (control) (Figs. 2C and E). Under these conditions,
HD cybrids were more susceptible to apoptosis induced by 10 nM STS
compared to CTR cybrids (pb0.01). In cells exposed to 10 nM STS, we
also observed a small increase in the number of necrotic cells, when
compared to untreated conditions (control) (pb0.05), but no
differences were observed between HD and CTR cybrids (Fig. 2D).
However, no signiﬁcant differences caused by STS (1 or 10 nM) were
observed on LDH release in both CTR and HD cybrids (Fig. 3B).
These results show that HD cybrids exhibit morphological
characteristics of apoptosis following 3-NP or STS treatment, being
the HD cybrids more susceptible to apoptosis compared with CTR
cybrids. Conversely, upon 3-NP exposure, CTR cybrids appear to
preferentially undergo a necrotic mode of cell death, whereas
incubation with STS does not differentially affect necrotic cell death
in HD and CTR cybrids.
Effect of 3-NP and STS on reactive oxygen species production
To explain the higher susceptibility of HD cybrids when exposed to
toxic stimuli, we examined the production of endogenous reactive
oxygen species (ROS). For this purpose, HD or CTR cybrids were
incubated in the absence or presence of 3-NP or STS and the levels of
superoxide ions and hydroperoxides were analyzed by measuring
ethidium or DCF ﬂuorescence, respectively.
Our results show no differences on superoxide levels between HD
and CTR cybrids under basal conditions (untreated HD vs. CTR
cybrids) (Fig. 4A). However, superoxide production increased in HD
cybrids upon exposure to 3-NP (0.1–10 mM), compared with
untreated conditions (control) (Fig. 4B). A signiﬁcant difference in
superoxide production in HD compared to CTR cybrids was only
observed for the higher concentration of 3-NP tested (10 mM)
(pb0.05). Incubation with STS (0.1–10 nM) caused a signiﬁcant
increase in superoxide production in HD cybrids, as compared to CTR
or untreated cybrids. Similarly to 3-NP, exposure to STS did not affect
the levels of superoxide in CTR cybrids (Fig. 4C).
By measuring DCF ﬂuorescence we demonstrate that under basal
conditions HD cybrids are endowed with a signiﬁcant higher amount
of hydroperoxides production, compared to CTR cybrids (pb0.01)
(Fig. 4D); however, no differences between HD and CTR cybrids were
observed when the cells were subjected to increasing concentrations
of 3-NP (Fig. 4E). Incubation with 10 mM 3-NP increased hydroper-
oxides production, in HD and CTR cybrids, compared to untreated
conditions (control) (pb0.001) (Fig. 4E). Incubation with STS
produced a dose-dependent increase in hydroperoxides production
in HD cybrids compared to untreated conditions (control) and CTR
cybrids (Fig. 4F), suggesting that HD cybrids are more susceptible to
STS-induced hydroperoxide production. A signiﬁcant increase in
hydroperoxide production in CTR cybrids was only observed in the
presence of the highest concentration of STS tested (10 nM) (pb0.01).
Effect of 3-NP and STS on caspase-3 activation
Since HD cybrids exhibited a higher percentage of cells displaying
apoptotic morphology (as determined in Fig. 2), we also investigated
the effect of 3-NP and STS on caspase-3 activation in both CTR and HD
cybrids (Figs. 5A and B). Although no signiﬁcant changes were
observed in CTR cybrids subjected to mitochondrial inhibition,
treatment with 10 mM 3-NP was effective in inducing caspase-3-
like activity in HD cybrids, when compared to untreated cybrids
(control) (pb0.001) or with CTR cybrids (pb0.01) (Fig. 5A). STS
incubation also caused a signiﬁcant increase in caspase-3 activity inoptosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
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Fig. 4. ROS production in HD and CTR cybrids. Cells were incubated in the absence or in the presence of 3-NP (0.1, 1 and 10mM) or STS (0.1, 1 or 10 nM) for 24 h or 15 h, respectively.
The relative levels of superoxide ions (A, B and C) were determined following ethidium ﬂuorescence after a pre-incubation with 5 μM DHE for 1 h, and the levels of hydroperoxides
(D, E and F) were measured following DCF ﬂuorescence after a 30 min incubation with 20 μM DCFH2-DA. Results are expressed as the mean±S.E.M. from 3 independent
experiments. Statistical analysis was performed by two-way ANOVA, followed by Bonferroni post test. ⁎pb0.05, ⁎⁎pb0.01 and ⁎⁎⁎pb0.001 when compared to CTR cybrids and
#pb0.05, ##pb0.01, ###pb0.001 when compared to control (untreated) conditions.
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COHD cybrids in the presence of the highest (10 nM) concentration of STStested, when compared to control conditions (untreated HD cybrids)
(pb0.01) (Fig. 5B). However, we did not observe signiﬁcant differ-
ences in the susceptibility of HD cybrids compared to CTR cybrids
when examining caspase-3 activity in response to STS (Fig. 5B),
despite the observation of a signiﬁcant number of apoptotic nuclei in
these conditions (Fig. 2C). These data were conﬁrmed by α-spectrin
cleavage into 150 and 120 kDa fragments, induced by 3-NP or STS
exposure (data not shown).
Effect of 3-NP on pro-apoptotic Cyt c, AIF, Bax, Bak, and Bim, and
anti-apoptotic Bcl-2 protein levels
Because cell death, including DNA fragmentation, caspase-3-like
activation and superoxide production were more evident in HDPlease cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
doi:10.1016/j.expneurol.2010.01.002cybrids exposed to 3-NP, we characterized in more detail the levels of
pro- and anti-apoptotic proteins involved in 3-NP-induced apoptosis
in this model. The levels of both mitochondrial and cytosolic
cytochrome c, Bax and Bcl-2 and mitochondrial Bak, Bim and AIF
were analyzed by western blotting in HD and CTR cybrids (Fig. 6).
Cytochrome cwas released in a signiﬁcantmanner frommitochondria
of HD cybrids subjected to 10 mM 3-NP, when compared to both
untreated HD cybrids (control) (pb0.05) or CTR cybrids (pb0.01)
(Fig. 6A). Interestingly, when statistical analysis was performed by
unpaired Student's t test in control conditions, a signiﬁcant increase in
cytochrome c in cytosol of HD vs. CTR cybrids was also detected
(pb0.05). Slight changes in cytochrome c release under basal
conditions seem to correlate with a small decrease in mitochondrial
membrane potential. AIF, which induces apoptotic cell death through
a caspase-independent pathway, was released in a similar manneroptosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
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Fig. 5. Caspase-3 activation induced by 3-NP (A) or STS (B) in HD and CTR cybrids. Cells
were incubated in the absence or in the presence of 3-NP (1 and 10 mM) or STS (1 or
10 nM) for 24 h and 15 h, respectively. Caspase-3-like activity was measured by
following the cleavage of the colorimetric substrate Ac-DEVD-pNA. The activity is
expressed as the increase in optic density values above the control (untreated cybrids).
Results are expressed as the mean±S.E.M. from 10–12 independent experiments
performed in duplicates. Statistical analysis was performed by two-way ANOVA,
followed by Bonferroni post test. ⁎⁎pb0.01 when compared to CTR cybrids; ##pb0.01,
###pb0.001 when compared to control (untreated) conditions.
9I.L. Ferreira et al. / Experimental Neurology xxx (2010) xxx–xxx
ARTICLE IN PRESSUN
CO
RR
ECfrom HD and CTR cybrids mitochondria upon exposure to 3-NP (Fig.6B). The pro-apoptotic protein Bim was present in higher amounts inmitochondria derived from non-treated (control) HD, compared to
CTR, cybrids (pb0.01 analyzed by t test), but exposure to 3-NP did not
highly affect Bim expression in HD cybrids (Fig. 6C). Interestingly, for
the highest concentration of 3-NP tested (10 mM), CTR cybrids
showed a signiﬁcant increase in Bim levels in the mitochondria when
compared to untreated conditions (control) (pb0.05) or with HD
cybrids exposed to 3-NP (pb0.001) (Fig. 6C). Incubation with 3-NP
did not signiﬁcantly affect the levels of the proapoptotic protein Bak in
mitochondria from both HD and CTR cybrids. However, our results
demonstrate that under basal conditions (untreated cybrids) the
levels of Bak are higher in HD than in CTR cybrids (pb0.05) (Fig. 6D).
Treatment with 3-NP (1 and 10 mM) increased the translocation of
Bax from the cytosol to the mitochondria in both CTR and HD cybrids
(pb0.05); however, no signiﬁcant differences were observed between
HD and CTR cybrids (Fig. 6E). Finally, cytosolic or mitochondrial levels
of the anti-apoptotic protein Bcl-2 were unaffected under basal or 3-
NP-treated conditions in both HD and CTR cybrids (Fig. 6F).
Discussion
Mitochondria are central in the process of apoptosis, a mechanism
leading to neuronal loss in neurodegenerative disorders like HD
(Kroemer and Reed, 2000; Beal, 2005; García-Martínez et al., 2007;
Yang et al., 2008). In the present study we provide evidence thatPlease cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
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human HD cybrids show subtle mitochondrial modiﬁcations. Indeed,
HD cybrids are more susceptible than CTR cybrids to mitochondrial-
dependent cell degeneration produced by the mitochondrial complex
II inhibitor 3-NP and the classic apoptotic inducer STS. In HD cybrids,
treatment with 3-NP caused the release of mitochondrial cytochrome
c, the subsequent activation of caspase-3, as well as the release of
mitochondrial AIF. This effect appears to be mediated by mitochon-
drial translocation of Bax. Moreover, increasedmitochondrial levels of
Bim and Bak, a slight decrease in mitochondrial membrane potential
concomitant with the release of cytochrome c, and increased
hydroperoxide production in non-treated HD cybrids may explain
the increased susceptibility to apoptosis caused by exposure to stress
inducers (3-NP or STS). Conversely, CTR cybrids are more vulnerable
to necrotic cell death upon 3-NP treatment, and no changes in
caspase-3 activation are observed. Increased mitochondrial Bax, and
particularly Bim, may contribute to promote a different mode of cell
death in 3-NP treated-CTR cybrids.
Previous evidence showed that both nuclear and mitochondrial
genomes are damaged in the 3-NP chemically inducedHDmousemodel
and in the HD R6/2 transgenic mice (Acevedo-Torres et al., 2009).
Lymphocytes from HD patients have higher frequencies of mtDNA
deletions and oxidative stress, suggesting that CAG repeat instability,
and thus mutant huntingtin, are a causative factor in mtDNA damage
(Banoei et al., 2007). Moreover, decreased mtDNA content was
correlated with the length of CAG repeats in leukocytes from HD
patients (Liu et al., 2008). Data presented in Table 1 suggest that the
mtDNA sequence variations are not causal for HD in the patients
included in the present study, since some are also found in CTR cybrids.
Additionally, there is no information regarding theCAG repeat genotype
in the HD gene of CTR subjects, and thus we cannot exclude that they
may be carriers for the intermediate or expanded allele and that they
may develop any type of neurodegenerative disease later in life,
including dementia. The presence of mtDNA variations, including an
8656A N G variant in one patient, was recently shown in a screening
study for mutations in the tRNA(leu/lys) and MTATP6 genes of 20
patients with HD (Kasraie et al., 2008). However, the nucleotides 8915-
9207 of the same gene do not present any sequence variation in our
study. Table 1 also presents one HD cybrid line carrying the 3394T N C
mutation with status “unclear,” previously described in cases suffering
from Leber Hereditary Optic Neuropathy (LHON), which was shown to
be related with HD features (Morimoto et al., 2004). Despite these
observations, we cannot exclude that other genes outside the regions
investigatedmay be involved in the disease or thatmtDNA involvement
is either related to deletion events or copy number alterations.
UnchangedmtDNA sequence variations correlate with the fact that
no mitochondrial respiratory chain defects were found in HD,
compared to CTR cybrids. These results are in agreement with
previous data showing no substantial modiﬁcations in mitochondrial
complexes activity in cybrid cell lines containing mtDNA from HD
patients (Swerdlow et al., 1999). Furthermore, there were no
signiﬁcant changes in the activity of mitochondrial respiratory
complexes (I–IV) or in superoxide formation among the six HD
cybrid lines used in the current study. Thus, our data suggest that
other mitochondrial modiﬁcations induced by full-length and/or
fragments of mutant huntingtin, such as protein post-translational
modiﬁcations, are retained in HD cybrids, which may be related with
an interaction of mutant huntingtin with the organelle in HD carriers
platelets. However, we could not detect huntingtin associated with
the mitochondrial fractions derived from HD cybrids, as detected by
western blotting using the anti-huntingtin antibody MAB2166
(Chemicon) (data not shown). Although HD cybrids do not express
mutant huntingtin and thus cannot be directly compared withmodels
expressing mutant huntingtin, in striatal cell lines expressing full-
lengthmutant huntingtin (derived from knock-inmice) no signiﬁcant
effects on respiratory complexes activities were observed either
(Milakovic and Johnson, 2005).optosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
10 I.L. Ferreira et al. / Experimental Neurology xxx (2010) xxx–xxx
ARTICLE IN PRESSMitochondrial dysfunction has been frequently associated with
increased generation of ROS, promoting intracellular oxidative stress
and leading to protein, lipid and DNA oxidation. Indeed, oxidative
damage was shown to play an important role in the pathogenesis and
progression of HD in the R6/2 transgenic mousemodel (Perluigi et al.,
2005) and also in post-mortem samples obtained from the striatum
and cortex of human HD brain (Sorolla et al., 2008). Our data also
demonstrate that, under basal conditions, HD cybrids are endowed
with a signiﬁcant higher production of hydroperoxides when
compared to CTR cybrids. These data differ from a previous study
showing no evidence of ROS generation, as measured with DCFH2-DA
in untreated HD cybrids (Swerdlow et al., 1999); however, these
authors did not exclude a subtle mitochondrial pathology in these
cells. In agreement, we show that HD cybrids are more vulnerable
than CTR cybrids to produce superoxide upon 3-NP or STS treatment,
whereas increased hydroperoxide production was mainly evoked by
STS, suggesting that the presence of higher amounts of hydroper-UN
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EC
Fig. 6. Changes in cytosolic and mitochondrial levels of cytochrome c, AIF, Bax, Bim, Bak, and
NP (1 and 10 mM) for 24 h. Cytosolic and mitochondrial fractions were obtained as describe
and Bcl-2 (F) protein levels were analyzed byWestern blotting. α-Tubulin or Cox1 were used
results are expressed as the mean±S.E.M. from 3–10 independent experiments. Statistical a
and ⁎⁎⁎pb0.001 when compared to CTR cybrids; #pb0.05, ##pb0.01 when compared to cont
with CTR cybrids under control (untreated) conditions, and statistical analysis was perform
Please cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
doi:10.1016/j.expneurol.2010.01.002oxides in untreated HD cybrids masks the effect caused by 3-NP-
induced mitochondrial inhibition.
The mitochondrial toxin 3-NP was shown to cause energy
deﬁciency and cell death by necrosis and apoptosis in striatal, cortical
and hippocampal cells (Behrens et al., 1995; Pang and Geddes, 1997;
Almeida et al., 2004, 2006; Ruan et al., 2004; Brouillet et al., 2005), and
both processes of cell damage have been proven to involve
mitochondria (Kroemer and Reed, 2000). In the present work,
exposure of HD cybrid cell lines to 3-NP or STS caused DNA
fragmentation and moderate caspase-3 activation, evidencing an
increased susceptibility of HD cybrids to apoptosis. However, 3-NP
treated CTR cybrids died predominantly by necrosis, not involving
caspase-3 activation. Recent data obtained in our laboratory using the
same cybrid lines also showed that endogenous levels of ATP are
higher in HD cybrids compared to CTR cybrids (author's unpublished
data). Preserved ATP levels in HD cybrids may explain the preferential
mode of cell death by apoptosis.TE
D
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F
Bcl-2 in HD and CTR cybrids. Cells were incubated in the absence or in the presence of 3-
d in the Material and Methods and cytochrome c (A), AIF (B), Bim (C), Bak (D), Bax (E),
as loading controls for analysis of cytosolic or mitochondrial fractions, respectively. The
nalysis was performed by two-way ANOVA, followed by Bonferroni post test. ⁎⁎pb0.01
rol (untreated) conditions. §pb0.05 and §§pb0.01 when the HD cybrids were compared
ed by using Student's t test.
optosis in Huntington's disease human cybrids, Exp. Neurol. (2010),
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Mutant huntingtin interaction with the mitochondria, as previ-
ously observed in neuronal mitochondrial membranes of YAC72
transgenic mice (Panov et al., 2002), may cause mitochondrial
abnormalities leading to cytochrome c release, and a decrease in
mitochondrial membrane potential. These authors also observed that
defects in mitochondrial calcium handling in HD brain mitochondria
may underlie HD pathology. Similar effects were observed by us in
YAC128 HD striatal neurons upon excitotoxic stimuli (Oliveira et al.,
2006). However data presented by Swerdlow et al., 1999, showed no
differences in CCCP-evoked cytosolic calcium between HD and CTR
cybrids, suggesting equivalent mitochondrial calcium handling.
We have recently reported that 3-NP causes mitochondrial-
dependent apoptotic neuronal death through the release of cytochrome
c and consequent activation of caspases, or the release of AIF in cortical
neurons (Almeida et al., 2004, 2006, 2009). Our present data
demonstrate an increase in cytochrome c and AIF release from
mitochondria, the translocation of the pro-apoptotic protein Bax to
mitochondria, but no changes on the levels of Bak or the anti-apoptotic
protein Bcl-2 in HD cybrids exposed to 3-NP. These data appear to be
consistent with possible subtle effects of mutant huntingtin in the
mitochondria of HD cybrids. Indeed,mutant huntingtin fragmentswere
previously shown to directly induce the opening of the mitochondrial
permeability transition pore in isolated mouse liver mitochondria, with
the consequent release of cytochrome c (Choo et al., 2004) which leads
to caspase cascade activation.Myoblasts obtained frompresymptomatic
and symptomatic HD subjects also show mitochondrial depolarization,
cytochrome c release and increased activities of caspases 3, 8 and 9
(Ciammola et al., 2006). Increased Bax expression in B and T
lymphocytes, and monocytes from HD patients, but no alterations in
Bcl-2 expression levels were also recently observed by us in blood
samples from HD patients (Almeida et al., 2008). Moreover, it was
recently shown that Bax and Bak can mediate apoptosis without
discernable association with the putative BH3-only activators (Bim, BidPlease cite this article as: Ferreira, I.L., et al., Mitochondrial-dependent ap
doi:10.1016/j.expneurol.2010.01.002TE
D
and Puma) (Willis et al., 2007). Interestingly, and consistently with
moderate sustained modiﬁcations of mitochondrial function in HD
cybrids, non-treated HD cells showed moderate levels of cytosolic
cytochrome c and increasedmitochondrial levels of both Bim and Bak. It
was previously shown that cell death induction by Bim(S) can occur
independently of anti-apoptotic Bcl-2 protein binding, but requires Bim
(S) mitochondrial targeting (Weber et al., 2007). In the R6/1 mouse
model of HD, increased levels of Bim and Bid were observed at later
stages of the disease (García-Martínez et al., 2007). Moreover,
constitutive expression of the transgene Tet/HD94 mice resulted in
increased levels of Bim and Bid proteins, but only the Bid protein
returned to wild-type levels 5 months after mutant huntingtin
shutdown (García-Martínez et al., 2007).
Our results suggest that mtDNA sequence variation is not a primary
contributor to the development of HD pathology. Thus we hypothesize
that HD cybrids may retain abnormal mitochondria from the symp-
tomatic HD patient platelets. Indeed, both caspase-dependent and
independent cell damage occurs in HD cybrids in response to 3-NP
exposure, reﬂecting subtle modiﬁcations in mitochondria from HD
patients. These alterations are considerably less than those observed in
cybrid lines obtained from sporadic forms of Parkinson's (Esteves et al.,
2008) and Alzheimer's (Cardoso et al., 2004) disease. Nevertheless, this
ex vivo human mitochondrial HD model appears to be useful for
studying mitochondrial-dependent defects and elucidate cell death
mechanisms inducedby toxic stimuli in a sub-populationofHDpatients.
Moreover, the HD cybrids may be valuable for testing pharmacological
compounds associated with improved mitochondrial function.
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